Matrix Income & Growth 4 VCT plc (the "Company")
5 April 2012
Issue of Equity
The Company announces that on 4 April 2012 it allotted and issued 883,989 new
Ordinary Shares of 1p each ("Ordinary shares") under the Offer for Subscription
("the Offer") at a price of 123.5p per share.
Application has been made for the new Ordinary Shares to be admitted to the
Official List of the UK Listing Authority and dealings are expected to commence
on 13 April 2012.
Following this allotment the issued share capital of the Company is 28,748,870
Ordinary Shares of 1p each.
These new shares in the Company have been issued subsequent to the linked offer
for subscription with Matrix Income & Growth VCT plc and The Income & Growth
VCT plc to raise up to £21 million, launched on 20 January 2012 ("the Offer").
A total of £12.8 million has been raised to date under the Offer of which £4.3
million has been raised by The Income & Growth VCT plc.
For further information please contact:
Robert Brittain, for Matrix Private Equity Partners LLP, Company Secretary:
020 3206 7000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.